FDA Clears Caretaker Medical’s Patient Monitor for Continuous Hemodynamic Parameters
Digital health provider Caretaker Medical has received FDA 510(k) clearance for four new continuous hemodynamic parameters.
Digital health provider Caretaker Medical has received FDA 510(k) clearance for four new continuous hemodynamic parameters.
Cardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families.
Verichem’s HDL Cholesterol Verifier Kit contains HDL and LDL cholesterol and other lipid components from human serum free of potential interfering substances.
The Karius test detected bloodstream infections in 75% of cases as early as 3 days before pediatric leukemia patients became symptomatic.
Read MoreThe newly cleared diagnostic could help identify heart attacks several hours sooner than standard troponin tests—and help improve diagnoses in women.
Read MoreMeasurement of patient sPLA2-llA levels enables clinicians to gain a comprehensive overview of cardiovascular risk factors and can help them tailor treatment accordingly.
Read MoreAn international study shows that LDL cholesterol is unable to predict future cardiovascular events and fails to identify patients at the highest risk.
Read MoreThis companion article discusses American Diabetes Association targets for the blood glucose levels of diabetic patients, as measured with an HbA1c test.
Read MoreResearch found that Abbott’s high-sensitivity Troponin I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors.
Read MoreNano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read MoreThe study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MoreThe license encompasses both a novel method and bioinformatic tools that combine to improve the level of detection in NGS, allowing for the identification of ultrarare gene variants.
Read MoreThe new pathways will focus on conditions such as cardiovascular disease, kidney disease, and liver cancer.
Read MoreThe prototype is a mobile, low-cost, point-of-care screening device that takes measurements in a fast, reproducible, and reliable way, with minimal patient contact and minimal skills from the operator.
Read MoreThe MenoCheck assay was developed to aid physicians in determining the status of women during menopausal transition.
Read MoreThe simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read MoreThe test measures blood concentrations of plasma ceramides, a class of lipids that are highly linked to cardiovascular disease processes.
Read MoreThe 84-gene panel is designed to identify patients with a genetic signature for inherited premature coronary or atherosclerotic disease, such as familial hypercholesterolemia, as well as mature onset diabetes of the young.
Read More